MACQUARIE GROUP LTD - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 114 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q3 2021$4,000
-33.3%
1,7060.0%0.00%
Q2 2021$6,000
-64.7%
1,7060.0%0.00%
Q1 2021$17,000
-29.2%
1,706
-23.0%
0.00%
Q4 2020$24,000
+4.3%
2,2160.0%0.00%
Q3 2020$23,000
-50.0%
2,2160.0%0.00%
Q2 2020$46,000
+475.0%
2,216
-7.6%
0.00%
Q4 2017$8,0002,3970.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,043,212$46,578,00047.83%
Soleus Capital Management, L.P. 342,800$3,949,0003.81%
ACUTA CAPITAL PARTNERS, LLC 1,322,500$15,235,0003.77%
RTW INVESTMENTS, LP 6,386,607$73,574,0002.78%
Ghost Tree Capital, LLC 1,175,000$13,536,0002.58%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$5,530,0002.48%
VHCP Management III, LLC 946,234$10,901,0002.16%
Avoro Capital Advisors LLC 5,250,000$60,480,0001.78%
VHCP Management II, LLC 383,620$4,419,0001.16%
Rhenman & Partners Asset Management AB 650,000$7,488,0000.82%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders